Selected HIV-1 Env Trimeric Formulations Act as Potent Immunogens in a Rabbit Vaccination Model

• Leo Heyndrickx ,

  * E-mail: lheyndrickx@itg.be

  Affiliation Biomedical Department, Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Guillaume Stewart-Jones,

  Affiliation Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Marianne Jansson,

  Affiliation Department of Laboratory Medicine, Lund University, Lund, Sweden

  ⨯
• Hanneke Schuitemaker,

  Affiliation Department of Experimental Immunology, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands

  ⨯
• Emma Bowles,

  Affiliation Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Luigi Buonaguro,

  Affiliation Molecular Biology and Viral Oncogenesis Unit, Istituto Nazionale Tumori, Naples, Italy

  ⨯
• Berit Grevstad,

  Affiliation Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Lasse Vinner,

  Affiliation Statens Serum Institut, Copenhagen, Denmark

  ⨯
• Katleen Vereecken,

  Affiliation Biomedical Department, Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium

  ⨯
• Joe Parker,

  Affiliation Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

  ⨯
• Meghna Ramaswamy,

  Affiliation National Institute for Biological Standards and Control, Hertfordshire, United Kingdom

  ⨯
• Priscilla Biswas,

  Affiliation Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy

  ⨯
• Guido Vanham,

  Affiliations Biomedical Department, Virology Unit, Institute of Tropical Medicine, Antwerp, Belgium, Biomedical Department, University of Antwerp, Antwerp, Belgium

  ⨯
• Gabriella Scarlatti,

  Affiliation Viral Evolution and Transmission Unit, Division of Immunology, Transplantation and Infectious Diseases, San Raffaele Scientific Institute, Milan, Italy

  ⨯
• Anders Fomsgaard,

  Affiliations Statens Serum Institut, Copenhagen, Denmark, Clinical Institute, University of Southern Denmark, Odense, Denmark

  ⨯
•  [ ... ],
• on behalf of the NGIN Consortium
• [ view all ]
• [ view less ]